ClinicalTrials.gg
RecruitingNCT06764797tDCSUpdated Jan 8, 2025

Investigating the Efficacy of Combining Virtual Reality-Based Mirror Therapy (VRMT) and Transcranial Direct Current Stimulation (tDCS) to Improve Upper Limb Recovery in Patients with Stroke

A Phase 3 interventional study of Transcranial Direct Current Stimulation and Virtual reality in Stroke Rehabilitaion and Stroke, sponsored by King Saud University. Recruiting at 2 sites in Saudi Arabia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-08.

Sponsored by King Saud University · Phase 3, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by May 2025, 1 year 5 months ago, but the record still lists the study as recruiting.
  • Registered 1 year 3 months after the study started (first participant enrolled Sep 2023, registered Jan 2025).
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 30 studies in Stroke with a site in Saudi Arabia — 10 open to participants now, 11 under way, 1 of them phase 3. Stroke · Saudi Arabia.

Planned enrollment
3rd of 27
300 · median 40
Started
2023
with 4 others
Phase 3
2 of 30
1 open now
Primary completion
2025-05
later than 3 of 10 live
Registered
23rd of 30
by date
Lead sponsor
9 of 30
King Saud University

Among the 30 studies in Stroke with a site in Saudi Arabia, this one is the 3rd largest by planned enrollment of the 27 interventional ones that give a count, is one of 5 that started in 2023, is one of 2 in phase 3, reaches primary completion later than 3 of the 10 other live ones, and was the 23rd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

10 of the 30 studies in Stroke with a site in Saudi Arabia are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Saudi Arabia have not opened yet or have stopped. Only those recruiting at a site in Saudi Arabia →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 30 studies in Stroke with a site in Saudi Arabia, or all of them as a file.
02

Study summary

This study will investigate whether combining virtual reality-based mirror therapy (VRMT) and transcranial direct current stimulation (tDCS) alongside conventional physical therapy (CPT) will significantly improve hand function for patients with stroke compared to using VRMT or tDCS alone.

Read the detailed description

More than half of stroke survivors suffer from upper-limb dysfunction that persists years after stroke, negatively impacting patients' independence and, therefore, affecting their quality of life. Motor rehabilitation is required after a stroke to facilitate motor recovery. More importantly, finding new ways to maximize patients' motor recovery is a core goal of stroke rehabilitation. Thus, researchers have explored the potential benefits of using advanced technologies such as virtual reality-based mirror therapy (VRMT) and transcranial direct current stimulation (tDCS) to boost the brain's responses to interventions and maximize the effects of rehabilitation to improve upper-limb recovery post-stroke. However, the potential impact of combining VRMT and tDCS on upper limb functions for patients with stroke has not been explored. Therefore, the goal of this study is to investigate whether combining virtual reality-based mirror therapy (VRMT) with transcranial direct current stimulation (tDCS) alongside conventional physical therapy (CPT) will significantly improve hand function for patients with stroke compared to using VRMT or tDCS alone.

The participants will be randomly assigned into one of the four groups: (1) the anodal tDCS + VRMT group, (2) the anodal tDCS alone group, (3) the VRMT alone with sham tDCS group, and (4) the CPT with sham tDCS group. All groups will receive CPT as part of the treatment. Functional scales will be used before and after the intervention to assess upper motor functions. These measures include the Fugl-Meyer Assessment, Wolf Motor Function Test, Box and Block Test, Nine-Hole Pegboard Test, and Stroke Impact Scale-16 (SIS-16). In addition, physiological measures such as transcranial magnetic stimulation (TMS) and task-based fMRI.

03

Conditions studied

  • Stroke Rehabilitaion
  • Stroke

Browse trials for

Keywords

  • Virtual reality, Mirror therapy, non invasive brain stimulation, tDCS, stroke
  • transcranial direct current stimulation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years old.
  • Stroke patients with unilateral cerebral infarction or hemorrhage, more than three months following the stroke.
  • Adequate cognitive ability to follow instructions (The Arabic version of the scores > 24).
  • Modified Ashworth scale score \< 3.
  • Fugl-Meyer Assessment (FMA) score of 10-58 indicating moderate-to-severe arm impairment.

Exclusion criteria

Exclusion Criteria:

  • visual impairment and field defect or hemi-sensory inattention and unilateral neglect.
  • Wernicke's aphasia, or global aphasia, leads to difficulty following instructions.
  • Any to NIBS.
  • Other neurological conditions or participation in another study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    anodal tDCS combined with VRMT

    20 minutes of anodal tDCS combined with 45 minutes of VRMT

    Device: Transcranial Direct Current Stimulation compined with virtual reality based mirror therapy

  • Active comparator
    Anodal tDCS alone

    20 minutes of anodal tDCS alone

    Device: Transcranial Direct Current Stimulation

  • Active comparator
    VRMT alone, Sham tDCS

    45 minutes of VRMT alone, For the sham-tDCS, the current flow will be terminated after 30 seconds.

    Device: Virtual reality

  • Sham comparator
    Conventional Physical therapy alone, Sham tDCS

    45 minutes of conventional physical therapy, For the sham-tDCS, the current flow will be terminated after 30 seconds.

    Other: Conventional physical therapy

Interventions

  • DeviceTranscranial Direct Current Stimulation

    tDCS will be used during the sessions. The anodal tDCS (2 mA) will be applied for 20 minutes. Continuous, direct currents. The anodal electrode will be positioned over the ipsilesional primary motor cortex (M1) (C3 or C4, international 10-20 system) of the affected hemisphere and the cathodal electrode over the contralateral orbit.

  • DeviceVirtual reality

    The VRMT group will receive VRMT game-based training using their non-affected upper limb. using a semi-immersive motion-tracking device.

  • DeviceTranscranial Direct Current Stimulation compined with virtual reality based mirror therapy

    20 minutes of tDCS during 45 minutes of VRMT games.

  • OtherConventional physical therapy

    45 minutes of conventional physical therapy with sham tDCS

06

What researchers measure

Primary outcomes

  1. Fugl-Mayer Upper limb assessment (FMA)

    FMA is a performance-based impairment measure particular to strokes, designed to assess motor functioning, balance, sensory, and joint functionality. It consists of five domains, which have 155 total items. The full potential scale score is 226. Scale items are scored based on the ability to finish the item using a 3-point ordinal scale. Motor score: from 0 to 100, 66 points for the upper extremity and 34 points for the lower extremities.

    Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  2. Wolf motor function test (WMT)

    WMT, consisting of timed and practical tasks, measures the motor function of the upper extremity (UE). The WMFT has 17 items in the most common version. The first six items involved timed functional tasks; items 7 and 14 were strength tests, and the final nine analyzed the participants' movement quality while carrying out various tasks. Items scored on a 6-point scale, with lower scores indicating lower levels of functioning.

    Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  3. box and blocks test (BBT)

    BBT assesses manual dexterity of the hand. It requires subjects to lift and release 2.5 cm³ cubes to move them from one compartment to another. BBT comprises 150 blocks. The test should begin with the unaffected upper limb to practice and record baseline values. The score is defined as the number of blocks transferred correctly within 60 seconds.

    Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  4. Nine-Hole Peg Test (NHPT)

    NHPT was developed to assess finger dexterity. It is made up of a nine-peg square board. The board has holes on one end for the pegs to fit into, and it also has a shallow circular dish on the other for storing the pegs. The patient is instructed to quickly insert the pegs into the holes on the board after taking each one out of a container as part of the NHPT. Then, one by one, clients must bring the pegs out of the holes and put them back into the container. Scoring is according to how long it took them to finish the test activity, measured in seconds.

    Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).

Secondary outcomes

  1. Stroke impact scale-16 (SIS-16)

    SIS is a self-report health status measure specific to the stroke population. It consists of 16 items from the four physical domains (strength, hand function ADL/IADL, and mobility).

    Time frame: at baseline, and after 2 weeks, and after intervention ( 4 weeks).

  2. transcranial magnetic stimulation (TMS)

    TMS measures cortical excitability, which is non-invasive magnetic stimulation using brief-duration, fast-pulsating, or pulsed magnetic fields to induce electrical currents targeted at spatially separate parts of the cerebral cortex using a computerized, electromechanical medical device.

    Time frame: at baseline, and after intervention ( 4 weeks).

  3. Functional magnetic resonance imaging (fMRI)

    fMRI technique uses MRI technology to evaluate brain activity by looking for variations in blood flow. The coupling between cerebral blood flow and neuronal activation is the basis for this method. The participants will be trained on the task before the experimental session. A block design will be used in the fMRI scan; each fMRI scan lasts for 6 minutes, divided into six blocks with an interval of 30 seconds of task, 15 repeated contractions, each contraction lasting 2 seconds, interspersed with 30 seconds of rest.

    Time frame: at baseline, and after intervention ( 4 weeks).

07

Study locations

2 of 2 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for May 2025, 20 months after the start.

Of 93 non-industry phase 3 interventional studies under Stroke, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 27 and three quarters within 71. This study's planned 20 months is below that.

Counting every sponsor, half of 130 studies reached it within 44 months; a quarter within 27 and three quarters within 68.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2025
First posted
Jan 8, 2025
StartActual
Sep 19, 2023
Primary completionEst.
May 31, 2025
CompletionEst.
Jul 21, 2025
Last update
Jan 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06764797
Collaborators
King Fahad Medical City, King Saud Medical City
Responsible party
Dr. Alaa Albishi (Associate professor, King Saud University) — Principal investigator
First posted
Jan 8, 2025
Start date
Sep 19, 2023
Primary completion
May 31, 2025 (estimated)
Completion
Jul 21, 2025 (estimated)
Last update
Jan 8, 2025

Study contacts

Dr. Alaa M. Albishi, Assistant Professor
Contact
aalbeshi@ksu.edu.sa
+966555090015
Dr. Ahmad O Alokaily, Assistant Professor
Contact
aalokaily@ksu.edu.sa
+966557447442
Alaa M. Albishi, Doctor of Philosophy
principal investigator · King Saud University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion